Try our beta test site
61 studies found for:    parkinson's disease AND baylor
Show Display Options
Rank Status Study
21 Recruiting Study to Identify Clinical, Imaging and Biologic Markers of Parkinson Disease Progression
Condition: Parkinson Disease
Intervention: Drug: Datscan and AV-133
22 Unknown  A Longitudinal Observational Follow-up of the PRECEPT Study Cohort
Condition: Parkinson Disease
Intervention:
23 Terminated
Has Results
NET-PD LS-1 Creatine in Parkinson's Disease
Condition: Parkinson's Disease
Interventions: Drug: creatine;   Other: placebo
24 Completed Safety and Efficacy Study of Fipamezole in Treatment of Motor Dysfunctions in Parkinson's Disease
Condition: Parkinson's Disease
Intervention: Drug: fipamezole
25 Completed
Has Results
Efficacy and Safety of Carbidopa/Levodopa/Entacapone in Patients With Parkinson's Disease Requiring Initiation of Levodopa Therapy
Condition: Parkinson's Disease
Interventions: Drug: Carbidopa/levodopa/entacapone;   Drug: Immediate release carbidopa/levodopa
26 Completed
Has Results
Efficacy, Safety, and Tolerability of E2007 in Levodopa Treated Parkinson's Disease Patients With Motor Fluctuations
Condition: Parkinson's Disease
Interventions: Drug: 2 mg perampanel;   Drug: 4 mg perampanel;   Drug: placebo comparator
27 Completed Multiple Ascending Dose Study of PRX002 in Patients With Parkinson's Disease
Condition: Parkinson's Disease
Interventions: Drug: PRX002;   Other: Placebo
28 Active, not recruiting Safety and Efficacy of CERE-120 in Subjects With Parkinson's Disease
Condition: Idiopathic Parkinson's Disease
Interventions: Biological: CERE-120: Adeno-Associated Virus Delivery of Neurturin;   Procedure: Sham Surgery
29 Completed
Has Results
A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease (ADVANCE-PD).
Condition: Parkinson's Disease
Interventions: Drug: IPX066;   Drug: IR CD-LD
30 Completed Safinamide in Idiopathic Parkinson's Disease (IPD) With Motor Fluctuations, as add-on to Levodopa
Condition: Idiopathic Parkinson's Disease
Interventions: Drug: Safinimide 50-100 mg/day;   Drug: Matching Placebo
31 Completed
Has Results
Double-Blind, Multicenter, Sham Surgery Controlled Study of CERE-120 in Subjects With Idiopathic Parkinson's Disease
Condition: Idiopathic Parkinson's Disease
Interventions: Genetic: CERE-120 (Adeno-Associated Virus Serotype 2 [AAV2]-Neurturin [NTN]);   Procedure: Sham Surgery
32 Terminated
Has Results
Effects of Coenzyme Q10 (CoQ) in Parkinson Disease
Condition: Parkinson Disease
Interventions: Drug: Coenzyme Q10 with vitamin E;   Drug: placebo with vitamin E
33 Completed Deep Brain Stimulation to Treat Symptoms of Parkinson's Disease
Conditions: Parkinson Disease;   Movement Disorders
Intervention: Device: Libra Deep Brain Stimulation System
34 Completed A Trial to Explore the Potential Benefit of Safinamide on Cognitive Impairment Associated With Parkinson's Disease
Condition: Parkinson's Disease With Cognitive Impairments
Interventions: Drug: safinamide;   Drug: placebo
35 Terminated Efficacy and Safety Study of Aplindore in Patients With Early Parkinson Disease
Condition: Early Parkinson Disease
Intervention: Drug: aplindore MR tablets or Placebo
36 Completed Impulse Control Disorders in Parkinson's Patients Treated With Pramipexole and Other Agents (DOMINION Study)
Condition: Parkinson Disease
Intervention:
37 Terminated Safety and Efficacy Study of CEP-1347 in the Treatment of Parkinson's Disease
Condition: Parkinson Disease
Interventions: Drug: CEP-1347 10mg;   Drug: CEP1347 25mg;   Drug: CEP-1347 50mg;   Other: Placebo Comparator
38 Completed
Has Results
Study of Antidepressants in Parkinson's Disease
Conditions: Parkinson Disease;   Depression
Interventions: Drug: paroxetine;   Drug: venlafaxine;   Other: placebo
39 Recruiting National Parkinson Foundation Quality Improvement Initiative
Condition: Parkinson's Disease
Intervention:
40 Completed A Study to Evaluate Fixed Dose Carbidopa/Levodopa/Entacapone Versus Immediate Release Carbidopa/Levodopa
Condition: Parkinson's Disease
Intervention: Drug: capsules containing: carbidopa (25 mg), levodopa (100 mg), entacapone (200 mg)

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.